2017 tables: Institutions - chemistry - corporate

The 2017 tables are based on Nature Index data from 1 January 2016 to 31 December 2016.

Table criteria

# Institution Share 2015 Share 2016 Count 2016 Change in Adjusted Share 2015-2016*
1 Merck & Co., Inc., United States of America (USA) 16.85 23.35 38 47.3%
2 IBM Corporation, United States of America (USA) 22.48 15.97 33 -24.5%
3 Pfizer Inc., United States of America (USA) 10.17 13.69 23 43.1%
4 Amgen Inc., United States of America (USA) 5.53 6.87 11 32.2%
5 Dow Inc., United States of America (USA) 7.39 6.49 21 -6.6%
6 Thermo Fisher Scientific Inc., United States of America (USA) 4.40 6.18 25 49.3%
7 Bristol-Myers Squibb (BMS), United States of America (USA) 7.75 3.96 13 -45.7%
8 Bruker Corporation, United States of America (USA) 4.59 3.42 24 -20.7%
9 Johnson & Johnson, United States of America (USA) 3.41 2.65 5 -17.2%
10 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 1.66 2.40 13 53.3%
11 HRL Laboratories LLC, United States of America (USA) 1.28 2.31 3 92.0%
12 HP Inc., United States of America (USA) 0.50 2.13 3 347.5%
13 AbbVie Inc., United States of America (USA) 1.06 2.03 4 103.2%
14 Waters Corporation, United States of America (USA) 4.44 2.02 7 -51.6%
15 Seattle Genetics, Inc., United States of America (USA) 1.00 2.00 2 112.6%
15 Q2 Solutions, United States of America (USA) 2.00 2 N/A
16 Agilent Technologies, Inc., United States of America (USA) 2.06 1.83 6 -5.5%
17 Biogen Inc., United States of America (USA) 1.80 3 N/A
18 Eli Lilly and Company, United States of America (USA) 3.40 1.76 10 -44.9%
19 Colgate-Palmolive Company, United States of America (USA) 1.49 3 N/A
20 New England Biolabs, Inc. (NEB), United States of America (USA) 1.67 1.33 2 -14.9%
21 E. I. du Pont de Nemours and Company (DuPont), United States of America (USA) 1.55 1.26 4 -13.4%
22 Gelest, Inc., United States of America (USA) 1.25 3 N/A
23 Promega Corporation, United States of America (USA) 2.12 1.19 3 -40.5%
24 NuMat Technologies, United States of America (USA) 0.90 1.18 2 39.0%
25 General Motors (GM), United States of America (USA) 0.84 1.14 5 45.1%
26 Hysitron, Inc., United States of America (USA) 0.77 1.14 6 57.8%
27 Danaher Corporation, United States of America (USA) 3.54 1.14 4 -65.8%
28 Chevron Corporation, United States of America (USA) 2.02 1.12 8 -40.9%
29 Leidos Holdings, Inc., United States of America (USA) 1.87 1.00 9 -43.1%
30 Vertex Pharmaceuticals Incorporated, United States of America (USA) 2.12 1.00 1 -50.0%
30 Alexion Pharmaceuticals, Inc., United States of America (USA) 3.00 1.00 1 -64.6%
30 Biodesy, Inc., United States of America (USA) 1.00 1 N/A
30 Selecta Biosciences, Inc., United States of America (USA) 1.00 1 N/A
30 BioMedomics, Inc., United States of America (USA) 1.00 1 N/A
30 Philip Morris International Inc. (PMI), United States of America (USA) 1.00 1 N/A
30 Western Digital Corporation, United States of America (USA) 1.00 1 N/A
30 Momenta Pharmaceuticals, Inc., United States of America (USA) 1.00 1 N/A
31 Polyera Corporation, United States of America (USA) 0.80 0.99 6 30.7%
32 Microsoft Corporation, United States of America (USA) 0.98 4 N/A
33 Constellation Pharmaceuticals, Inc., United States of America (USA) 0.90 2 N/A
34 VUV Analytics, Inc., United States of America (USA) 0.81 3 N/A
35 Diagnostics For All (DFA), United States of America (USA) 0.67 0.75 1 19.6%
35 Aptitude Medical Systems Inc., United States of America (USA) 0.75 1 N/A
36 Covance Inc., United States of America (USA) 0.71 1 N/A
37 Procter & Gamble (P&G), United States of America (USA) 0.71 2 N/A
38 Archer Daniels Midland Company (ADM), United States of America (USA) 0.69 2 N/A
39 Ionis Pharmaceuticals, Inc., United States of America (USA) 0.14 0.67 1 396.1%
39 Leco Corporation, United States of America (USA) 0.67 1 N/A
40 Protea Biosciences, Inc., United States of America (USA) 0.13 0.65 2 452.8%
41 Tetranov International, Inc., United States of America (USA) 0.10 0.65 3 586.6%
42 Honeywell International, Inc., United States of America (USA) 0.66 0.65 7 4.0%
43 Physical Electronics, Inc., United States of America (USA) 0.63 2 N/A
44 Materia, Inc., United States of America (USA) 0.60 1 N/A
44 Senomyx, Inc., United States of America (USA) 0.60 1 N/A
45 Liox Power, Inc., United States of America (USA) 0.58 2 N/A
46 Charles River Laboratories, Inc., United States of America (USA) 0.86 0.58 2 -28.5%
47 Gilead Sciences, Inc., United States of America (USA) 1.71 0.53 2 -67.1%
48 AECOM, United States of America (USA) 0.06 0.50 2 750.5%
48 Firebird Biomolecular Sciences, LLC, United States of America (USA) 0.58 0.50 2 -8.2%
48 Afton Chemical Corporation, United States of America (USA) 0.50 0.50 1 6.3%
48 PHASIQ, Inc., United States of America (USA) 0.50 1 N/A
48 Biomime, Inc., United States of America (USA) 0.50 1 N/A
48 Excellims Corporation, United States of America (USA) 0.50 1 N/A
48 CoorsTek Inc., United States of America (USA) 0.50 1 N/A
48 Econous Systems, Inc., Canada 0.50 1 N/A
48 Advachrom, United States of America (USA) 0.50 1 N/A
48 908 Devices Inc., United States of America (USA) 0.50 2 N/A
49 Alnylam Pharmaceuticals, Inc., United States of America (USA) 0.07 0.46 2 630.9%
50 SunPreme, United States of America (USA) 0.44 1 N/A
50 NTBS, United States of America (USA) 0.44 2 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.